Tg Therapeutics (TGTX) Other Non-Current Assets (2010 - 2026)

Tg Therapeutics' Other Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.4 million for Q1 2026.

• In Q1 2026, Other Non-Current Assets rose 3.84% year-over-year to $1.4 million; the TTM figure through Mar 2026 stood at $1.4 million (up 3.84% YoY), while the FY2025 annual figure was $1.3 million, up 3.39% from the prior year.
• Other Non-Current Assets was $1.4 million for Q1 2026 at Tg Therapeutics, up from $1.3 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $2.3 million in Q4 2023 to a low of $1.3 million in Q1 2022.
• Historically, Other Non-Current Assets has averaged $1.4 million across 5 years, with a median of $1.3 million in 2024.
• The sharpest annual moves came in 2023 and 2024: Other Non-Current Assets jumped 81.38% in 2023, then slumped 43.79% in 2024.
• A 5-year view of Other Non-Current Assets shows it stood at $1.3 million in 2022, then soared by 81.38% to $2.3 million in 2023, then tumbled by 43.79% to $1.3 million in 2024, then gained by 3.39% to $1.3 million in 2025, then grew by 0.75% to $1.4 million in 2026.
• The last three Other Non-Current Assets figures came in at $1.4 million (Q1 2026), $1.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.